2022 Q3 Form 10-Q Financial Statement

#000119312522299530 Filed on December 07, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $260.0K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $260.7K $0.00 $708.00
YoY Change 1371984.21%
Operating Profit -$260.7K -$25.00
YoY Change
Interest Expense $40.00K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $51.65K $2.00 $0.00
YoY Change
Pretax Income -$210.0K $27.00 -$708.00
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$209.0K $2.00 -$708.00
YoY Change 1100131.58% 1100.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.400M $210.0K $20.00K
YoY Change
Cash & Equivalents $1.398M $209.9K $24.85K
Short-Term Investments
Other Short-Term Assets $263.5K $30.00K $30.00K
YoY Change
Inventory
Prepaid Expenses $10.00K
Receivables
Other Receivables
Total Short-Term Assets $1.681M $230.0K $50.00K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $82.04M
YoY Change
Other Assets $103.6K $260.0K $140.0K
YoY Change
Total Long-Term Assets $82.15M $260.0K $140.0K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.681M $230.0K $50.00K
Total Long-Term Assets $82.15M $260.0K $140.0K
Total Assets $83.83M $490.0K $190.0K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $460.0K
YoY Change
Accrued Expenses $210.0K $170.0K $120.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $190.0K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $820.0K $470.0K $160.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.800M
YoY Change
Total Long-Term Liabilities $2.800M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $820.0K $470.0K $160.0K
Total Long-Term Liabilities $2.800M $0.00 $0.00
Total Liabilities $3.620M $470.0K $160.0K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$1.791M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.791M $2.385K $21.38K
YoY Change
Total Liabilities & Shareholders Equity $83.83M $490.0K $190.0K
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$209.0K $2.00 -$708.00
YoY Change 1100131.58% 1100.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$130.0K $80.00K -$150.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$82.00M
YoY Change
Cash From Investing Activities -$82.00M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 83.32M 100.0K 25.00K
YoY Change
NET CHANGE
Cash From Operating Activities -130.0K 80.00K -150.0
Cash From Investing Activities -82.00M
Cash From Financing Activities 83.32M 100.0K 25.00K
Net Change In Cash 1.190M 180.0K 24.85K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$130.0K $80.00K -$150.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7619
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001922331
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41506
dei Entity Registrant Name
EntityRegistrantName
GLOBAL STAR ACQUISITION INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-2508938
dei Entity Address Address Line1
EntityAddressAddressLine1
1641 International Drive Unit 208
dei Entity Address City Or Town
EntityAddressCityOrTown
McLean
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22102
dei City Area Code
CityAreaCode
(703)
dei Local Phone Number
LocalPhoneNumber
790-0717
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 us-gaap Cash
Cash
1397490
CY2021Q4 us-gaap Cash
Cash
0
CY2022Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
10530
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
25000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25071
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
263473
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1681493
CY2021Q4 us-gaap Assets Current
AssetsCurrent
50071
CY2022Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
82043907
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
0
CY2022Q3 glst Deferred Offering Costs Noncurrent
DeferredOfferingCostsNoncurrent
0
CY2021Q4 glst Deferred Offering Costs Noncurrent
DeferredOfferingCostsNoncurrent
31000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103580
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0
CY2022Q3 us-gaap Assets
Assets
83828980
CY2021Q4 us-gaap Assets
Assets
81071
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
456833
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
0
CY2022Q3 glst Accrued Offering Costs Current
AccruedOfferingCostsCurrent
55349
CY2021Q4 glst Accrued Offering Costs Current
AccruedOfferingCostsCurrent
15000
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
150637
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1596
CY2022Q3 glst Advances From Related Party Current
AdvancesFromRelatedPartyCurrent
0
CY2021Q4 glst Advances From Related Party Current
AdvancesFromRelatedPartyCurrent
42384
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
112250
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2022Q3 glst Overallotment Liability Current
OverallotmentLiabilityCurrent
44975
CY2021Q4 glst Overallotment Liability Current
OverallotmentLiabilityCurrent
0
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
820044
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58980
CY2022Q3 glst Deferred Underwriting Commission Noncurrent
DeferredUnderwritingCommissionNoncurrent
2800000
CY2021Q4 glst Deferred Underwriting Commission Noncurrent
DeferredUnderwritingCommissionNoncurrent
0
CY2022Q3 us-gaap Liabilities
Liabilities
3620044
CY2021Q4 us-gaap Liabilities
Liabilities
58980
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
82000000
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24770
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1791350
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2909
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1791064
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22091
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83828980
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81071
CY2022Q3 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
3666
CY2021Q3 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
0
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
3666
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
0
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
257030
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
257763
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
78
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
260696
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
19
us-gaap Operating Expenses
OperatingExpenses
261429
us-gaap Operating Expenses
OperatingExpenses
78
CY2022Q3 glst Income Earned On Investments Held In Trust Account
IncomeEarnedOnInvestmentsHeldInTrustAccount
43907
CY2021Q3 glst Income Earned On Investments Held In Trust Account
IncomeEarnedOnInvestmentsHeldInTrustAccount
0
glst Income Earned On Investments Held In Trust Account
IncomeEarnedOnInvestmentsHeldInTrustAccount
43907
glst Income Earned On Investments Held In Trust Account
IncomeEarnedOnInvestmentsHeldInTrustAccount
0
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
126
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
153
us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7619
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
51652
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
51679
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-209044
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-19
us-gaap Net Income Loss
NetIncomeLoss
-209750
us-gaap Net Income Loss
NetIncomeLoss
-78
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22091
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-708
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
21383
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2385
CY2022Q3 glst Adjustment To Additional Paid In Capital Sale Of Units In Public Offering Net Of Offering Costs
AdjustmentToAdditionalPaidInCapitalSaleOfUnitsInPublicOfferingNetOfOfferingCosts
379243
CY2022Q3 glst Stock Issued During Period Value Private Placement Units
StockIssuedDuringPeriodValuePrivatePlacementUnits
4535275
CY2022Q3 glst Adjustment To Additional Paid In Capital Proceeds From Sale Of Rights Net Of Costs
AdjustmentToAdditionalPaidInCapitalProceedsFromSaleOfRightsNetOfCosts
53094
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
69000
CY2022Q3 glst Remeasurement Of Classa Common Stock To Redemption Value
RemeasurementOfClassaCommonStockToRedemptionValue
-6640017
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-209044
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1791064
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
23790
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-59
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
23731
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
0
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
23731
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-19
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
23712
us-gaap Net Income Loss
NetIncomeLoss
-209750
us-gaap Net Income Loss
NetIncomeLoss
-78
glst Income Earned On Investments Held In Trust Account
IncomeEarnedOnInvestmentsHeldInTrustAccount
43907
glst Income Earned On Investments Held In Trust Account
IncomeEarnedOnInvestmentsHeldInTrustAccount
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7619
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-15071
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
71
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
263473
glst Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
103580
glst Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
456833
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-507
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
149041
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
0
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-42384
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
656
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49768
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
82000000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82000000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1397500
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
820000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
79200000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
4563000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
185000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
185000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
glst Proceeds From Due From Sponsor
ProceedsFromDueFromSponsor
25000
glst Proceeds From Due From Sponsor
ProceedsFromDueFromSponsor
0
glst Due To Related Party
DueToRelatedParty
112500
glst Due To Related Party
DueToRelatedParty
0
glst Repayment Of Due From Sponsor
RepaymentOfDueFromSponsor
10530
glst Repayment Of Due From Sponsor
RepaymentOfDueFromSponsor
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
442462
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
83447258
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1397490
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1397490
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
glst Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
40349
glst Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
0
glst Deferred Underwriters Commission Non Cash Transactions
DeferredUnderwritersCommissionNonCashTransactions
2800000
glst Deferred Underwriters Commission Non Cash Transactions
DeferredUnderwritersCommissionNonCashTransactions
0
glst Remeasurement Adjustment Of Common Stock To Redemption Value
RemeasurementAdjustmentOfCommonStockToRedemptionValue
6640017
glst Remeasurement Adjustment Of Common Stock To Redemption Value
RemeasurementAdjustmentOfCommonStockToRedemptionValue
0
glst Fair Value Of Over Allotment Option At Issuance
FairValueOfOverAllotmentOptionAtIssuance
52594
glst Fair Value Of Over Allotment Option At Issuance
FairValueOfOverAllotmentOptionAtIssuance
0
CY2022Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2800000
glst Minimum Percent Of Balance In The Trust Account For Business Combination
MinimumPercentOfBalanceInTheTrustAccountForBusinessCombination
0.90
us-gaap Proceeds From Issuance Of Trust Preferred Securities
ProceedsFromIssuanceOfTrustPreferredSecurities
82000000
CY2022Q3 glst Sale Of The Placement Units Per Unit
SaleOfThePlacementUnitsPerUnit
10.25
CY2022Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2800000
glst Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2022Q3 us-gaap Cash
Cash
1397490
CY2022Q3 glst Working Capital
WorkingCapital
861449
CY2022Q3 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2022Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
303600
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.033
CY2022Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
303600
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.033
CY2022Q3 us-gaap Share Price
SharePrice
10.1
CY2022Q3 us-gaap Share Price
SharePrice
10.1
CY2022Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
82043907
CY2022Q3 glst Working Capital Net
WorkingCapitalNet
861400
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div>
CY2022Q3 us-gaap Cash
Cash
1397490
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
82043907
CY2022Q3 glst Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
glst Period After Which The Warrants Are Exercisable
PeriodAfterWhichTheWarrantsAreExercisable
P30D
glst Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Common Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemableCommonStock
6600000
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At September 30, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. The cash at bank is $1,397,490 as of September 30, 2022. </div></div>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q3 us-gaap Cash
Cash
1397490
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
119720
glst Underwriting Discount Paid Per Unit
UnderwritingDiscountPaidPerUnit
0.2
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
1600000
glst Deferred Underwriting Commission Per Unit
DeferredUnderwritingCommissionPerUnit
0.35
CY2022Q3 glst Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
2800000
glst Reimbursement Of Underwriting Expenses
ReimbursementOfUnderwritingExpenses
800000
glst Warrants Exercisable Term From The Closing Of Ipo
WarrantsExercisableTermFromTheClosingOfIPO
P12M
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0
glst Number Of Days After Which Business Combination With In Which Securities Registration Shall Be Effective
NumberOfDaysAfterWhichBusinessCombinationWithInWhichSecuritiesRegistrationShallBeEffective
P60D

Files In Submission

Name View Source Status
0001193125-22-299530-index-headers.html Edgar Link pending
0001193125-22-299530-index.html Edgar Link pending
0001193125-22-299530.txt Edgar Link pending
0001193125-22-299530-xbrl.zip Edgar Link pending
d417279d10q.htm Edgar Link pending
d417279dex311.htm Edgar Link pending
d417279dex312.htm Edgar Link pending
d417279dex321.htm Edgar Link pending
d417279dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
glst-20220930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
glst-20220930_cal.xml Edgar Link unprocessable
glst-20220930_lab.xml Edgar Link unprocessable
glst-20220930_def.xml Edgar Link unprocessable
d417279d10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
glst-20220930_pre.xml Edgar Link unprocessable